The use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: A multicenter, open-label randomized clinical trial

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-000625-19

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary objectives are: - increase in survival - improvement in the response to standard medical treatment and avoid/delay the occurrence of refractory ascites in patients with cirrhosis and uncomplicated ascites.


Critère d'inclusion

  • ascites in patients with hepatic cirrhosis

Liens